Serum Institute
Image Source: India TV

In a recent report, the Serum Institute of India (SII) has said that it will provide Covidshield vaccine to private hospitals for Rs. 600 per dose while the same will be provided to the state government for Rs. 400. A statement issued by the SII on its Twitter handle said that the Institute will address the limited capacity by increasing the vaccine production over the coming two months. However, people are not happy with the difference in prices of Covidshield between states and centers. On Wednesday I.e. 22nd April Bollywood actor Farhan Akhtar by posting a tweet questioned the Serum Institute of India about not delivering its Covidshield vaccine at the same price to everyone.

Taking a jab at the world’s largest manufacturer of vaccines, Farhan Akhtar took to his Twitter handle and questioned the company over the disparity in prices of the vaccine.

The Bollywood actor wrote that can a spokesperson for Serum Institute India please make us understand why Indian states should not receive Covidshield at the same price as the center? He added that if any such statement citing the reason has already been issued, can anybody provide him with the link.

Table of Contents

Public above age of 18 now eligible to get vaccine: Govt. of India

The tweet from Farhan Akhtar came a few hours after the Serum Institute of India announced the prices for Covidshield for the center and states ahead of 1st May 2021 for the Covid-19 vaccination drive.

The central government this week said that starting from 1st May, everyone above 18 years of age will be allowed to get vaccinated. The center further liberalized the vaccination drive to permit states, industrial establishments, and private hospitals to purchase the vaccine doses directly from the manufacturers.

So far, the Serum Institute of India has been selling the Covidshield Vaccine to the center at Rs. 150 per dose.

ALSO READ: THANK YOU CORONAVIRUS HELPERS: A TRIBUTE FROM GOOGLE DOODLE

FOR MORE SUCH UPDATES FOLLOW US ON INSTAGRAM

LEAVE A REPLY

Please enter your comment!
Please enter your name here